Heart disease and sleeping pills are one of those combinations that can come with a potential risk. Although insomnia is frequent among the healthy population, around 20% of medical patients are also struggling with it. Among medical patients, the group that struggles...
A clinical investigator from the University of Kansas School of Medicine, Patrick M. Moriarty, co-led a clinical trial testing a drug focusing on individuals who have inherited a condition subjecting them to high cholesterol irrespective of diet or lifestyle. The...
The UK’s University of Oxford is conducting a new study that could prevent young people from suffering a fatal cardiac arrest due to a rare inherited heart disease. Financed by the British Heart Foundation, the research seeks to address CPVT, also known as...
Akcea Therapeutics along with its parent company, Ionis Pharmaceuticals, announced positive topline results from the Phase 2 study of AKCEA-ANGPTL3-LRx in patients with hypertriglyceridemia, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). The study met...
Akcea Therapeutics, a majority owned affiliate of Ionis Pharmaceuticals, announced positive topline results from the Phase 2 study of AKCEA-APOCIII-LRx in the treatment of patients with hypertriglyceridemia who are at risk for or have established cardiovascular...
According to Dr. Irving Kent Loh, chief medical officer and co-founder of Infermedica, an artificial intelligence in healthcare company focused on clinical decision support, the future of healthcare is headed for vast changes in the next decade. Dr. Loh, a...
